Skip to main content

Table 1 Clinical profiles of all 27 patients, including case nos. 1–10 in the EDB group (n = 10), case nos. 11–19 in the EDD group (n = 9) and case nos. 20–27 in the ESD group (n = 8)

From: A comparison of endolymphatic duct blockage, endolymphatic sac drainage and endolymphatic sac decompression surgery in reversing endolymphatic hydrops in Meniere’s disease

Case no.

Age/gender

Side

endolymphatic sac surgery

Disease of duration (months)

Hearing (dB)

Vertigo Attacks (a/mon)

EVVR (%)

CH

Follow-up (months)

Pre

Post

Pre

Post

First

Second

Third

First

Second

Third

1

37/M

L

EDB

10

53.8.

47.5

4.2

1.8

56.42

58.25

59.55

I

I

I

21

2

39/F

R

EDB

22

42.5

27.5

3.8

0

74.68

76.55

15.45

I

I

N

20

3

61/F

L

EDB

14

57.5

62.5

3.8

0.7

46.55

45.60

52.10

I

I

I

19

4

52/F

L

EDB

16

41.3

57.5

3.0

3.3

37.85

39.80

52.30

I

I

II

18

5

46/M

R

EDB

32

58.8

38.8

2.5

0

82.65

84.35

47.45

II

II

II

18

6

48/M

R

EDB

16

52.5

56.3

2.5

0

54.55

58.75

46.25

I

I

I

16

7

62/F

R

EDB

66

48.8

21.3

4.3

0

78.73

82.45

13.89

II

II

I

16

8

48/M

L

EDB

12

42.5

45

3.7

1.7

41.30

40.28

45.15

I

I

I

15

9

52/M

L

EDB

42

62.5

60

2.5

0

66.82

68.30

64.25

II

II

II

14

10

49/F

R

EDB

12

45

46.3

3.3

0

50.65

53.58

47.48

I

I

1

13

11

29/F

R

EDD

45

63.8

60

4.2

0.5

78.65

76.45

79.35

II

II

II

26

12

49/M

L

EDD

12

52.5

67.5

3.3

0

72.55

18.25

25.35

I

N

N

22

13

48/M

R

EDD

36

57.5

63.8

2.8

1.8

66.45

68.33

78.66

II

II

II

17

14

66/F

L

EDD

55

65

68.8

4.0

0

62.56

12.25

65.30

I

N

N

17

15

39/F

R

EDD

24

43.8

28.8

2.5

0

52.66

15.30

18.35

I

N

N

15

16

62/F

L

EDD

18

60

57.5

4.3

0

65.60

10.20

18.25

II

N

N

15

17

47/F

L

EDD

13

37.5

35

3.8

0

56.44

54.80

52.46

I

I

I

15

18

56/M

R

EDD

72

65

77.5

3.0

0.8

72.22

74.55

76.36

II

II

II

14

19

37/F

L

EDD

11

27.5

33.8

1.8

0.5

48.35

51.25

54.64

I

I

I

13

20

73/F

R

ESD

96

72.5

77.5

1.5

1.2

81.75

83.55

79.45

II

II

II

24

21

40/F

R

ESD

30

57.5

51.3

2.8

0.8

63.30

66.66

64.25

II

II

II

18

22

37/F

R

ESD

24

47.5

32.5

1.8

0.5

48.85

49.40

45.36

I

I

I

18

23

60/M

L

ESD

48

65

72.5

1.5

0

72.30

76.35

70.22

II

II

II

15

24

39/M

L

ESD

18

42.5

48.8

3.0

2.3

52.55

54.33

57.28

I

I

I

15

25

49/F

R

ESD

42

52.5

57.5

3.3

0.7

58.25

61.30

63.45

II

II

II

14

26

45/M

L

ESD

11

37.5

48.8

2.5

2.3

45.72

49.35

55.36

I

I

I

14

27

52/F

R

ESD

26

55

51.3

1.8

0

55.65

58.56

59.18

I

I

I

13

  1. The bold number represents a reduction in endolymphatic hydrops or hearing improvement, whereas the underlined number represents an increase in endolymphatic hydrops or hearing worsening prior to and following surgery
  2. a/mon, attacks per month; EVVR, endolymph to vestibule-volume ratio; CH, cochlear hydrops; Pre, pre-surgery; Post, post-surgery; F, female; M, male; R, right; L, left; Mon, month; N, no endolymphatic hydrops; I, mild endolymphatic hydrops; II, significant endolymphatic hydrops; EDB, endolymphatic duct blockage, EDD, endolymphatic sac drainage, ESD, endolymphatic sac decompression
Back to article page

Journal of Otolaryngology - Head & Neck Surgery

ISSN: 1916-0216

Contact us